English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

R1 Therapeutics raises $77.5 million in series A funding for kidney disease drug
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA approves Protagonist and J&J’s Icotyde for plaque psoriasis treatment
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA approves Johnson & Johnson's Icotyde for plaque psoriasis treatment
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Johnson & Johnson leads pharma revenue as Lilly rises on obesity drug sales
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Studies link adult thymus health to longevity and disease risk, researchers say
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Review links menopause to earlier Alzheimer’s risk and calls for sex-specific prevention
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Study links taller height to higher risk of endometriosis and atrial fibrillation
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

Researchers identify glutathione as key nutrient fueling cancer cell growth

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes